Clinical Trial Update: Plasma Exchange Therapy for Post- COVID-19 Condition: A Pilot, Randomized Double-Blind Study [Phase 2]

View source ↗

Summary

A Phase 2 randomized double-blind pilot trial evaluating plasma exchange therapy for Post-COVID-19 Condition has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-covid-19 Condition

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: Post-COVID19 Condition | Phase 2 | Status: COMPLETED